Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.2M Hold
4,817,664
﹤0.01% 2286
2026
Q1
$25M Sell
4,817,664
-1,605,888
-25% -$10M ﹤0.01% 2351
2025
Q4
$47M Hold
6,423,552
0.01% 1687
2025
Q3
$64M Buy
+6,423,552
New +$71.1M 0.01% 1387
2022
Q2
Sell
-22,857
Closed -$285K 10458
2022
Q1
$285K Hold
22,857
﹤0.01% 5103
2021
Q4
$546K Buy
+22,857
New +$554K ﹤0.01% 4910

Other funds holding ENVX

UBS Group's ENVX Position: Q2 2026 in Review

UBS Group reduced its Enovix (ENVX) stake by 8% in Q2 2026, selling an estimated $3.08M and leaving 5,305,746 shares worth $32.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

UBS Group first reported a position in ENVX in Q1 2021 and has held it in 21 quarters since. The position peaked at $43.7M in Q4 2025. 299 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • UBS Group held 5,305,746 shares of Enovix worth $32.2M as of Q2 2026.
  • UBS Group sold 464,325 Enovix shares in Q2 2026, an estimated $3.08M.
  • Enovix made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2194 holding.
  • UBS Group first reported a position in Enovix in Q1 2021 and has held it in 21 quarters since.
  • UBS Group's Enovix position peaked at $43.7M in Q4 2025.
  • 299 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.